ALHC (NASDAQ: ALHC) insider files to sell 318,152 shares via Form 144

Rhea-AI Filing Summary

ALHC submitted a Form 144 notice covering a planned sale of 318,152 shares of common stock, with an aggregate market value of $6,681,192.00. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, where the stock is listed, with an approximate sale date of 01/06/2026. The filing notes that 200,091,742 shares of common stock were outstanding.

The seller acquired 228,152 common shares on 12/31/2025 via performance stock units and 90,000 common shares on 09/30/2019 through restricted and performance stock units, both from the issuer. Over the past three months, sales disclosed include 100,000 shares on 01/02/2026 for $2,003,450.00, and additional transactions in December 2025, some labeled as 10b5-1 sales for Dawn Maroney. The signatory represents they are not aware of undisclosed material adverse information about the issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	318152	6681192.00	200091742	01/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/31/2025	Performance Stock Units	Issuer			228152	12/31/2025	N/A
Common	09/30/2019	Restricted and Performance Stock Units	Issuer			90000	09/30/2019	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DAWN MARONEY 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	01/02/2026	100000	2003450.00
DAWN MARONEY 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	12/29/2025	282070	5286747.38
10b5-1 Sales for DAWN MARONEY 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	12/15/2025	113319	2267154.93
10b5-1 Sales for DAWN MARONEY 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	12/12/2025	16681	333960.29

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ALHC Form 144 filing disclose?

The Form 144 discloses a planned sale of 318,152 shares of ALHC common stock with an aggregate market value of $6,681,192.00, to be sold under Rule 144.

How many ALHC shares are planned to be sold and through which broker?

The filing covers 318,152 common shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with trading on NASDAQ.

When are the ALHC shares expected to be sold and how many shares are outstanding?

The approximate sale date listed is 01/06/2026. The filing states there were 200,091,742 common shares outstanding.

How were the ALHC shares being sold originally acquired?

The seller acquired 228,152 shares on 12/31/2025 via performance stock units and 90,000 shares on 09/30/2019 via restricted and performance stock units, in each case from the issuer.

What ALHC share sales occurred in the past three months?

Disclosed past three-month sales include 100,000 shares on 01/02/2026 for $2,003,450.00, 282,070 shares on 12/29/2025 for $5,286,747.38, 113,319 shares on 12/15/2025 for $2,267,154.93, and 16,681 shares on 12/12/2025 for $333,960.29, with several entries labeled as 10b5-1 sales for Dawn Maroney.

What is the significance of the 10b5-1 references in the ALHC Form 144?

The past three-month sales table includes entries described as "10b5-1 Sales for DAWN MARONEY", indicating that certain transactions were carried out pursuant to trading instructions or a written trading plan intended to satisfy Rule 10b5-1 under the Exchange Act.

What representation does the seller make in the ALHC Form 144 notice?

By signing, the seller represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed, as required in the form's ATTENTION section.